Brief: Novonesis Q2 Organic Pro Forma Sales Growth Of 10%

Novozymes A/S

27/08/2024 16:03

Aug 27 (Reuters) - Novozymes A/S  NSISb.CO :
    * Q2 ORGANIC PRO FORMA SALES GROWTH OF 10%
    * INTERIM DIVIDEND APPROVED FOR 2024 AT DKK 2.00/SHARE (EUR
0.27).
    * INTEGRATION IS PROGRESSING VERY WELL; COST SYNERGIES
CONTINUE TO
BE ON TRACK WITH AN 80% RUN-RATE
    * SYNERGY REALIZATION AND PRIORITIZATION CONTINUES TO BE IN
FOCUS
THROUGHOUT THE COMPANY
    * H1 PRO FORMA NET SALES EUR 1,943.7 MILLION VERSUS EUR 
1,858.2
MILLION YEAR AGO
    * H1 PRO FORMA ADJUSTED EBITDA EUR 685.8 MILLION VERSUS EUR
627.2
MILLION YEAR AGO

Source text for Eikon:  ID:nGNE1Py8TV 
Further company coverage:  NSISb.CO 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))